Endocrinology

The SOLOIST-WHF trial indicates that SGLT2 inhibition may lead to an overall reduction in cardiovascular-related deaths and hospitalizations.

A systematic review and meta-analysis of 23 trials suggest adhering to a low carbohydrate diet for a 6-month period could facilitate remission of diabetes and lead to reductions in body weight.

A new study finds benefit to hemoglobin A1c reductions made following conception.

An analysis of data from questionnaires sent to more than 400 patients from a diabetes clinic in Europe gives insight into the impact of lockdown measures on body weight, HbA1c control, and perceived levels of stress and anxiety.

The study finds that individuals with mothers who had pregestational diabetes had a 2.3-fold increased risk of MS compared to those with non-diabetic mothers.

A double-blind, placebo-controlled trial is providing insight into the effects of saccharin use on the development of diabetes and glucose absorption in healthy patients.

An analysis of patients from 52 clinical sites details an apparent increase in risk of being hospitalized for diabetic ketoacidosis after contracting COVID-19 among Black patients compared to White patients.

If approved, the treatment would be the first SGLT2 inhibitor for patients with chronic kidney disease.

An analysis of OCT and OCTA scans from 129 diabetics suggests structural and vascular abnormalities of the retina can help predict cognitive decline in patients with type 1 diabetes.

Dr. Melissa Young, a practicing endocrinologist, offers her perspective on E/M changes set to take effect in January 2021.

Check out the latest emergency department minute quiz from Brady Pregerson, MD. This case report features a woman presenting to the ED complaining of anxiety, palpitations, and diaphoresis.

This article features the top 5 stories in Endocrinology Network's coverage of women's health during 2020.

The first approved generic product for injection glucagon is also indicated for diagnostic use, when appropriate.

This article features the top 5 stories in Endocrinology Network's coverage of diabetes management in 2020.

Check out our latest Emergency Department Minute Quiz, which features a man in his 30s with an ankle injury and swollen hands.

Dr. Melissa Young, an endocrinologist, reflects on her experiences during 2020 as part of the My Year in COVID-19 feature series.

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

Results of the INVESTED trial are shedding light on cardiovascular and pulmonary outcomes among patients with high-risk cardiovascular disease receiving standard-dose vs high-dose influenza vaccines.

An analysis of more than 7k patients with CAN data from the ACCORD trial suggest intensive blood pressure and blood glucose control could reduce risk of cardiovascular autonomic neuropathy.

A randomized trial sponsored by the National Eye Institute is comparing the effects of a surgical vs anti-VEGF therapy in patients with proliferative diabetic retinopathy.

An analysis of more than 25 studies with more than 1 million patients is giving an overview of how the timing of a diabetes diagnosis can impact risk of complications later in life.

Learn why one organization prioritizes screening for diabetic retinopathy among patients with diabetes.

A discussion centered around optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.

Amputations have increased 30% among diabetic patients since the pandemic began.

An analysis of 15k patients hospitalized with COVID-19 suggests metformin use was associated with significant reductions in mortality among women who were obese or had type 2 diabetes.